Review Article
Management of Failed Bioprosthetic Aortic Valves: Mitigating Complications and Optimizing Outcomes
Table 1
Risk /protective factors for SVD.
| | Hazard ratio (95% confidence interval) | value |
| Risk factors | Younger age | | | Age per 1 year decrease | 1.10 (1.06, 1.12) | <0.0001 | Increasing BSA | 1.77 (1.04, 3.01) | 0.034 | PPM | 1.95 (1.56, 2.43) | <0.001 | Smoking | 2.28 (1.37, 3.79) | 0.0015 |
| Protective factor | Anticalcification preparation | 0.41 (0.19, 0.89) | 0.025 | Older age | | | Age >60 years | 0.12 (0.06, 0.23] | <0.0001 | Age >65 years | 0.06 (0.02, 0.21) | <0.0001 | Age >70 years | 0.06 (0.01, 0.28) | 0.0004 |
|
|
BSA = body surface area; PPM = patient prosthesis mismatch. Adapted from Ochi A, Cheng K, Zhao B, Hardikar AA, Negishi K. Patient Risk Factors for Bioprosthetic Aortic Valve Degeneration: A Systematic Review and Meta-Analysis. Heart Lung Circ. 2020; 29 : 668–678.
|